Medical Director, Oncology Cell Therapy at GlaxoSmithKline Pharma GmbH
Greater Philadelphia Area
National Cancer Institute (NCI)
Visiting Fellow in Cancer Vaccine Immunotherapy Combinations
May 2007 to June 2011
Bristol-Myers Squibb
Lead, Translational Medicine, Immuno-Oncology Hematology
June 2015 to April 2017
Princeton, NJ
Bristol-Myers Squibb
Lead, Clinical Biomarker, Early Clinical and Translational Research (ECTR) - Immuno-Oncology
December 2014 to April 2017
Princeton, NJ
National Cancer Institute (NCI)
Head, Molecular Immunology Group
June 2011 to December 2014
Bethesda, MD, USA
Ospedale Ferrarotto
Resident Physician in Stem Cell Transplant
September 2003 to May 2007
Catania Area, Italy
Università di Catania
Research Fellow in Neurodegenerative Disorders and Antiaging Therapy
September 2001 to August 2003
Catania Area, Italy
AZIENDA OSPEDALIERA PER L'EMERGENZA CANNIZZARO
Undergraduate Clinical Assistant in Geriatrics
September 1999 to October 2000
Catania Area, Italy
GlaxoSmithKline Pharma GmbH
Medical Director, Oncology Cell Therapy
Collegeville, PA
Bristol-Myers Squibb
Early Clinical Asset Lead, Oncology
April 2017 to December 2017
Princeton, NJ
Liceo Scientifico Galileo Galilei, Catania, Italy
Diploma in Science, Biology, Chemistry, Mathematics, Philosophy, Italian Literature, Latin.
1987 to 1992
National Cancer Institute (NCI), Bethesda, MD
Post Doctoral Fellowship in Therapeutic Cancer Vaccines, Therapeutic Cancer Vaccine - Immuno-Oncology
2007 to 2011
Università di Catania
Specialization in Clinical Biochamistry, Clinical Molecular Biology and Laboratory Medicine, 70/70 cum Laude
2002 to 2007
Università di Catania
Doctor of Medicine (MD), 110/110
1995 to 2002
Preclinical studies (in vivo and in vitro) of combining standard chemotherapy or targeted therapy with therapeutic cancer vaccines. Analysis of tumor vasculature normalization for the improvement of immunotherapy. Tested the effect of combining therapeutic cancer vaccines with anti-angiogenic tyrosine kinase inhibitors sunitinib and sorafenib, with docetaxel, and with the BCL2 inhibitor GX15-070 obatoclax to provide rationale for... Preclinical studies (in vivo and in vitro) of combining standard chemotherapy or targeted therapy with therapeutic cancer vaccines. Analysis of tumor vasculature normalization for the improvement of immunotherapy. Tested the effect of combining therapeutic cancer vaccines with anti-angiogenic tyrosine kinase inhibitors sunitinib and sorafenib, with docetaxel, and with the BCL2 inhibitor GX15-070 obatoclax to provide rationale for clinical trials. Described the Immunogenic Modulation of Tumor Phenotype from chemo-radio therapy.
What company does Benedetto Farsaci work for?
Benedetto Farsaci works for National Cancer Institute (NCI)
What is Benedetto Farsaci's role at National Cancer Institute (NCI)?
Benedetto Farsaci is Visiting Fellow in Cancer Vaccine Immunotherapy Combinations
What industry does Benedetto Farsaci work in?
Benedetto Farsaci works in the Pharmaceuticals industry.
Who are Benedetto Farsaci's colleagues?
Benedetto Farsaci's colleagues are Jodie Browne, Ruth Willis, laura williams, Christopher Pickles, David Blakey, carol montgomery, Alexandra Wren, Steven Polley, Ruth Barnard, and Philip Masdin
🎓 Education
Benedetto Farsaci currently holds his Doctor of Medicine (MD) from Università di Catania. Farsaci completed his undergraduate education at Liceo Scientifico Galileo Galilei in Catania, Italy in 1987. Farsaci then completed his Post Doctoral Fellowship in Therapeutic Cancer Vaccines, Therapeutic Cancer Vaccine - Immuno-Oncology at National Cancer Institute (NCI) in Bethesda, MD from 2007 to 2011. Farsaci then completed his Doctor of Medicine (MD) at Università di Catania in 1995.
Extraversion (E), Sensing (S), Feeling (F), Judging (J)
2 year(s), 5 month(s)
Unlikely
Likely
There's 97% chance that Benedetto Farsaci is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required
Benedetto Farsaci's Social Media Links
/company/g...